\-\ Texto\\:\\ \ \(0\)\
\-\ bp\\ 137\\/90\\ pulse\\ 112\\ resp\\ 28\\ wt\\ 11kg\\ ht\\ 80\\.6cm\\ bmi\\ 16\\.9\\ temp\\ 36\\.2\\&\\#730\\;c\\ \\ \\ \ \(0\)\
\-\ gen\\:\\ crying\\ but\\ consolable\\;\\ child\\ is\\ small\\ for\\ age\\ but\\ proportionate\\.\\ height\\ is\\ \\<\\ 5th\\ percentile\\ for\\ age\\,\\ weight\\ just\\ at\\ 5th\\ percentile\\ for\\ age\\.\\ \ \(0\)\
\-\ heent\\:\\ normal\\.\\ oropharynx\\ is\\ clear\\.\\ neck\\ supple\\ with\\ no\\ lymphadenopathy\\.\ \(0\)\
\-\ lungs\\:\\ ctab\ \(0\)\
\-\ cv\\:\\ no\\ murmurs\\,\\ rrr\ \(0\)\
\-\ abd\\:\\ distended\\ but\\ nontender\\.\\ \\+bs\\.\\ \\ palpation\\ c\\/w\\ large\\ firm\\ mass\\ filling\\ right\\ side\\ of\\ the\\ abdomen\\ and\\ extending\\ below\\ the\\ umbilicus\\.\\ lower\\ edge\\ of\\ mass\\ is\\ palpable\\ about\\ the\\ level\\ of\\ the\\ anterior\\ iliac\\ spine\\.\\ \ \(0\)\
\-\ gu\\:\\ only\\ superficial\\ visual\\ inspection\\ of\\ perineal\\ region\\.\\ normal\\ female\\ genitalia\\ with\\ no\\ labial\\ edema\\ or\\ obvious\\ rash\\.\\ \ \(0\)\
\-\ ext\\:\\ no\\ c\\/c\\/e\ \(0\)\
\-\ neuro\\:\\ cn\\ 2\\-12\\ intact\\,\\ reflexes\\ symmetric\\.\\ normal\\ gait\\.\ \(0\)\
\-\ skin\\:\\ no\\ lesions\\ or\\ rashes\\.\\ \\ \\ \ \(0\)\
\-\ soft\\ tissue\\,\\ right\\ renal\\ mass\\,\\ biopsies\\:\\ \\ tissue\\ suboptimal\\ for\\ definitive\\ evaluation\\.\\ small\\ round\\ blue\\ cell\\ neoplasm\\.\\ unable\\ to\\ evaluate\\ the\\ architecture\\ of\\ the\\ neoplasm\\.\\ immunostains\\ for\\ vimentin\\,\\ lca\\,\\ synaptophysin\\ and\\ chromogranin\\ all\\ appear\\ negative\\ while\\ keratin\\ appears\\ weakly\\ positive\\.\\ the\\ differential\\ diagnosis\\ includes\\ wilms\\ tumor\\,\\ clear\\ cell\\ sarcoma\\,\\ or\\ other\\ small\\ round\\ blue\\ cell\\ neoplasm\\,\\ although\\ the\\ negative\\ immunostains\\ would\\ seem\\ to\\ exclude\\ neuroblastoma\\,\\ lymphoma\\ and\\ ewing\\'s\\ sarcoma\\.\ \(0\)\
\-\ this\\ patient\\ was\\ initially\\ given\\ captopril\\ at\\ a\\ dose\\ of\\ 0\\.2mg\\/kg\\ bid\\ to\\ keep\\ her\\ bp\\ at\\ a\\ target\\ range\\ of\\ 100\\-110\\/70\\.\\ she\\ was\\ thought\\ to\\ have\\ tumor\\-induced\\ hypertension\\ that\\ would\\ improve\\ with\\ chemotherapy\\.\ \(0\)\
\-\ ct\\ in\\ the\\ axial\\ plane\\ demonstrates\\ a\\ heterogeneous\\ mass\\ in\\ the\\ right\\ kidney\\,\\ with\\ considerable\\ mass\\ effect\\.\\ the\\ liver\\ and\\ ivc\\ are\\ markedly\\ compressed\\ with\\ no\\ obvious\\ invasion\\.\\ initial\\ measurements\\ of\\ this\\ mass\\ were\\ 15\\.4\\ cm\\ in\\ the\\ craniocaudal\\ dimension\\,\\ 12\\.3\\ cm\\ in\\ the\\ ap\\ dimension\\,\\ and\\ 7\\.7\\ cm\\ in\\ the\\ lateral\\ dimension\\.\\ the\\ left\\ kidney\\ is\\ normal\\ with\\ no\\ evidence\\ of\\ masses\\ or\\ hydronephrosis\\.\\ \ \(0\)\
\-\ coronal\\ and\\ sagittal\\ reconstruction\\ views\\ demonstrate\\ a\\ well\\-circumscribed\\ mass\\ that\\ has\\ most\\ likely\\ infiltrated\\ the\\ right\\ renal\\ capsule\\.\\ cystic\\ regions\\ within\\ the\\ mass\\ are\\ most\\ notable\\ on\\ the\\ sagittal\\ view\\.\\ the\\ lateral\\ image\\ shows\\ medial\\ displacement\\ of\\ functioning\\ right\\ renal\\ parenchyma\\ \\(i\\.e\\.\\,\\ claw\\ sign\\)\\ with\\ contrast\\ excretion\\,\\ and\\ there\\ is\\ normal\\ excretion\\ from\\ the\\ left\\ kidney\\.\\ the\\ right\\ adrenal\\ gland\\ and\\ right\\ renal\\ vein\\ are\\ not\\ well\\ visualized\\.\\ \ \(0\)\
\-\ followup\\ ct\\ after\\ 5\\ weeks\\ of\\ preoperative\\ chemotherapy\\ shows\\ considerable\\ tumor\\ shrinkage\\ and\\ more\\ defined\\ areas\\ of\\ margination\\.\\ the\\ tumor\\ now\\ measures\\ 10\\.5\\ cm\\ in\\ the\\ craniocaudal\\ dimension\\,\\ 8\\ cm\\ in\\ the\\ ap\\ dimension\\,\\ and\\ 5\\.2\\ cm\\ in\\ the\\ lateral\\ dimension\\.\\ the\\ right\\ renal\\ vein\\ is\\ not\\ well\\ visualized\\.\ \(0\)\
\-\ sedated\\ abdominal\\ u\\/s\\ demonstrates\\ no\\ right\\ renal\\ vein\\ thrombus\\,\\ although\\ there\\ is\\ considerable\\ mass\\ effect\\ and\\ tortuosity\\ of\\ the\\ right\\ renal\\ vein\\.\\ the\\ ivc\\ is\\ clearly\\ visualized\\ with\\ no\\ evidence\\ of\\ intraluminal\\ thrombus\\.\\ flow\\ is\\ seen\\ throughout\\ the\\ lumen\\.\ \(0\)\
\-\ wilms\\â\\€\\™\\ tumor\\,\\ stage\\ i\\ \\(stage\\ iii\\ at\\ biopsy\\)\\ with\\ favorable\\ histology\ \(0\)\
\-\ wilms\\â\\€\\™\\ tumor\ \(0\)\
\-\ clear\\ cell\\ sarcoma\ \(2\)\
\-\ mesoblastic\\ nephroma\\ \ \(3\)\
\-\ nephroblastomatosis\ \(5\)\
\-\ neuroblastoma\ \(81\)\
\-\ complex\\ teratoma\ \(0\)\
\-\ cystic\\ renal\\ dysplasia\ \(5\)\
\-\ this\\ 2\\.5\\-year\\-old\\ girl\\ presented\\ to\\ her\\ pediatrician\\ in\\ italy\\ after\\ her\\ parents\\ noted\\ a\\ prominence\\ in\\ the\\ right\\ abdomen\\ after\\ bathing\\ her\\ in\\ march\\ 2004\\.\\ the\\ child\\ had\\ consistently\\ been\\ at\\ the\\ fifth\\ percentile\\ for\\ growth\\ up\\ to\\ that\\ point\\.\\ an\\ ultrasound\\ in\\ italy\\ revealed\\ a\\ 7\\ x\\ 8cm\\ abdominal\\ mass\\,\\ and\\ she\\ was\\ immediately\\ air\\-evac\\â\\€\\™d\\ to\\ wramc\\ for\\ further\\ evaluation\\ and\\ treatment\\.\ \(0\)\
\-\ wilms\\â\\€\\™\\ tumor\\ is\\ the\\ most\\ common\\ renal\\ tumor\\ of\\ childhood\\,\\ with\\ a\\ peak\\ incidence\\ at\\ 3\\-4\\ years\\ of\\ age\\.\\ it\\ is\\ thought\\ to\\ be\\ due\\ to\\ abnormal\\ proliferation\\ of\\ the\\ metanephric\\ blastema\\,\\ without\\ normal\\ differentiation\\ into\\ tubules\\ and\\ glomeruli\\.\\ wilms\\â\\€\\™\\ tumors\\ are\\ histologically\\ heterogeneous\\,\\ comprised\\ of\\ three\\ cell\\ types\\ in\\ varying\\ distributions\\:\\ blastemal\\ cells\\,\\ stromal\\ cells\\,\\ and\\ epithelial\\ cells\\.\\ while\\ each\\ of\\ these\\ components\\ is\\ variable\\ in\\ its\\ level\\ of\\ differentiation\\,\\ anaplasia\\ \\(either\\ focal\\ or\\ diffuse\\)\\ is\\ associated\\ with\\ an\\ unfavorable\\ prognosis\\.\\ nephroblastomatosis\\ is\\ characterized\\ by\\ the\\ presence\\ of\\ multiple\\ nephrogenic\\ rests\\,\\ which\\ are\\ foci\\ of\\ abnormally\\ present\\ renal\\ blastemal\\ cells\\.\\ it\\ is\\ thought\\ to\\ be\\ a\\ precursor\\ of\\ wilms\\â\\€\\™\\,\\ as\\ the\\ presence\\ of\\ intralobular\\ nephrogenic\\ rests\\ has\\ been\\ associated\\ with\\ the\\ development\\ of\\ wt\\.\ \(0\)\
\-\ grossly\\,\\ wt\\ is\\ an\\ intrarenal\\ mass\\ with\\ both\\ solid\\ and\\ cystic\\ components\\.\\ although\\ it\\ distorts\\ the\\ anatomy\\ of\\ the\\ collecting\\ ducts\\,\\ it\\ rarely\\ grows\\ into\\ the\\ renal\\ pelvis\\,\\ ureter\\,\\ or\\ bladder\\.\\ if\\ invasion\\ of\\ the\\ collecting\\ system\\ occurs\\,\\ a\\ patient\\ may\\ present\\ with\\ hematuria\\ and\\/or\\ obstruction\\.\\ the\\ tumor\\ is\\ usually\\ surrounded\\ by\\ a\\ pseudocapsule\\.\\ it\\ may\\ contain\\ areas\\ of\\ necrosis\\,\\ which\\ lead\\ to\\ hemorrhage\\ and\\ the\\ appearance\\ of\\ cystic\\ structures\\.\\ true\\ cysts\\ may\\ also\\ be\\ seen\\.\\ extension\\ of\\ the\\ tumor\\ mass\\ into\\ the\\ corresponding\\ renal\\ vein\\ is\\ seen\\ in\\ about\\ 40\\%\\ of\\ cases\\,\\ and\\ is\\ associated\\ with\\ a\\ higher\\ incidence\\ of\\ surgical\\ complications\\.\\ extension\\ into\\ the\\ ivc\\ is\\ associated\\ with\\ a\\ 40\\%\\ rate\\ of\\ surgical\\ complications\\.\\ large\\ tumors\\ that\\ involve\\ vital\\ structures\\ are\\ associated\\ with\\ a\\ higher\\ rate\\ of\\ surgical\\ complications\\,\\ most\\ notably\\ tumor\\ rupture\\ which\\ could\\ then\\ lead\\ to\\ recurrence\\.\\ they\\ are\\ considered\\ inoperable\\ without\\ preoperative\\ chemotherapy\\.\ \(0\)\
\-\ radiologically\\,\\ wt\\ may\\ be\\ confused\\ with\\ congenital\\ mesoblastic\\ nephroma\\,\\ in\\ the\\ first\\ year\\ of\\ life\\.\\ a\\ mesoblastic\\ nephroma\\ is\\ a\\ solitary\\ hamartoma\\ which\\ consists\\ of\\ immature\\ renal\\ stromal\\ cells\\.\\ it\\ lacks\\ blastemal\\ cells\\ and\\ neoplastic\\ metanephric\\ elements\\,\\ making\\ it\\ easy\\ to\\ differentiate\\ from\\ wt\\ pathologically\\.\\ however\\,\\ it\\ is\\ a\\ unilateral\\,\\ single\\,\\ solid\\ mass\\ arising\\ from\\ the\\ kidney\\ that\\ may\\ appear\\ heterogeneous\\ with\\ areas\\ of\\ necrosis\\ and\\ hemorrhage\\ on\\ ultrasound\\ and\\/or\\ ct\\.\\ unlike\\ wt\\,\\ mesoblastic\\ nephroma\\ tends\\ to\\ infiltrate\\ the\\ renal\\ parenchyma\\ and\\ does\\ not\\ form\\ a\\ pseudocapsule\\.\\ it\\ is\\ more\\ prominent\\ in\\ neonates\\,\\ with\\ a\\ peak\\ age\\ at\\ diagnosis\\ of\\ 3\\.5\\ months\\;\\ however\\,\\ isolated\\ cases\\ of\\ mesoblastic\\ nephroma\\ in\\ childhood\\ and\\ adulthood\\ have\\ been\\ documented\\.\\ radiation\\ therapy\\ and\\ chemotherapy\\ increase\\ the\\ chances\\ for\\ overall\\ morbidity\\,\\ while\\ excision\\ alone\\ results\\ in\\ cure\\.\ \(0\)\
\-\ the\\ national\\ wilms\\â\\€\\™\\ tumor\\ study\\ group\\ \\(nwtsg\\)\\ recommends\\ surgical\\ staging\\ of\\ every\\ case\\ with\\ the\\ following\\ breakdown\\:\ \(0\)\
\-\ stage\\ i\\:\\ the\\ tumor\\ is\\ isolated\\ to\\ the\\ kidney\\ and\\ has\\ been\\ excised\\ completely\\.\ \(0\)\
\-\ stage\\ ii\\:\\ the\\ tumor\\ had\\ extended\\ beyond\\ the\\ kidney\\ but\\ is\\ excised\\ completely\\.\\ capsular\\ penetration\\,\\ renal\\ vein\\ involvement\\,\\ and\\ renal\\ sinus\\ involvement\\ may\\ be\\ found\\.\\ biopsy\\ of\\ the\\ tumor\\ results\\ in\\ some\\ local\\ spill\\.\ \(0\)\
\-\ stage\\ iii\\:\\ there\\ is\\ residual\\ non\\-hematogenous\\ tumor\\ s\\/p\\ resection\\,\\ but\\ it\\ is\\ confined\\ to\\ the\\ abdomen\\.\\ the\\ resected\\ specimen\\ may\\ have\\ histologically\\ positive\\ margins\\,\\ or\\ part\\ of\\ the\\ tumor\\ has\\ infiltrated\\ the\\ abdominal\\ cavity\\.\\ lymph\\ node\\ findings\\ are\\ positive\\ and\\/or\\ peritoneal\\ implants\\ are\\ found\\.\\ \\ \\ \\ \ \(0\)\
\-\ stage\\ iv\\:\\ hematogenous\\ or\\ lymph\\ node\\ metastasis\\ has\\ occurred\\ outside\\ the\\ abdomen\\ or\\ pelvis\\.\\ \ \(0\)\
\-\ stage\\ v\\:\\ there\\ is\\ bilateral\\ renal\\ involvement\\ at\\ the\\ time\\ of\\ diagnosis\\.\\ each\\ side\\ is\\ assigned\\ a\\ stage\\ from\\ i\\ to\\ iii\\,\\ and\\ histology\\ is\\ based\\ on\\ biopsy\\ findings\\.\\ \ \(0\)\
\-\ postoperative\\ chemotherapy\\ and\\ radiotherapy\\ are\\ based\\ on\\ surgical\\ staging\\ and\\ follow\\ the\\ guidelines\\ of\\ the\\ nwtsg\\:\ \(0\)\
\-\ stage\\ i\\ with\\ favorable\\ or\\ unfavorable\\ histology\\ or\\ stage\\ ii\\ with\\ favorable\\ histology\\:\ \(0\)\
\-\ nephrectomy\ \(68\)\
\-\ postoperative\\ chemotherapy\\ with\\ vincristine\\ and\\ actinomycin\\ d\\ \\(18\\ week\\ course\\)\ \(0\)\
\-\ stage\\ ii\\ with\\ focal\\ anaplasia\\ or\\ stage\\ iii\\ with\\ favorable\\ histology\\ or\\ focal\\ anaplasia\\:\ \(0\)\
\-\ nephrectomy\ \(68\)\
\-\ abdominal\\ irradiation\\ \\(1080\\ cgy\\)\ \(0\)\
\-\ chemotherapy\\ with\\ vincristine\\,\\ actinomycin\\ d\\,\\ and\\ doxorubicin\\ \\(24\\ week\\ course\\)\ \(0\)\
\-\ stage\\ iv\\ with\\ favorable\\ histology\\ or\\ focal\\ anaplasia\\:\\ \ \(0\)\
\-\ nephrectomy\ \(68\)\
\-\ abdominal\\ irradiation\\ according\\ to\\ local\\ stage\\ \ \(0\)\
\-\ bilateral\\ pulmonary\\ irradiation\\ and\\ pcp\\ prophylaxis\\ \ \(0\)\
\-\ chemotherapy\\ with\\ vincristine\\,\\ actinomycin\\ d\\,\\ and\\ doxorubicin\\ \\(24\\ week\\ course\\)\ \(0\)\
\-\ stage\\ ii\\ through\\ stage\\ iv\\ with\\ diffuse\\ anaplasia\\:\ \(0\)\
\-\ nephrectomy\ \(68\)\
\-\ abdominal\\ irradiation\ \(0\)\
\-\ whole\\ lung\\ irradiation\\ \ \(0\)\
\-\ chemotherapy\\ with\\ vincristine\\,\\ doxorubicin\\,\\ etoposide\\,\\ and\\ cyclophosphamide\\ \\(24\\ week\\ course\\)\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ stage\\:\\ 0\\.04121593700555021\ \(0\)\
\-\ anaplasia\\:\\ 0\\.031150241780800347\ \(0\)\
\-\ renal\\:\\ 0\\.03084599600055631\ \(0\)\
\-\ wilms\\:\\ 0\\.026165445438482232\ \(0\)\
\-\ mesoblastic\\:\\ 0\\.02380239181020022\ \(0\)\
\-\ wt\\:\\ 0\\.023250801047878276\ \(0\)\
\-\ tumor\\:\\ 0\\.022527008357436734\ \(0\)\
\-\ nephroma\\:\\ 0\\.02236965291229151\ \(0\)\
\-\ irradiation\\:\\ 0\\.022086816489416825\ \(0\)\
\-\ histology\\:\\ 0\\.021531514370387826\ \(0\)\
\-\ dimension\\:\\ 0\\.02079220672171739\ \(0\)\
\-\ favorable\\:\\ 0\\.019637533165883448\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.019481633969093845\ \(0\)\
\-\ \\:\\:\\ 0\\.017573177351091613\ \(0\)\
\-\ blastemal\\:\\ 0\\.01722057507436018\ \(0\)\
\-\ \\-\\:\\ 0\\.01682860068071288\ \(0\)\
\-\ actinomycin\\:\\ 0\\.016360931735614957\ \(0\)\
\-\ vincristine\\:\\ 0\\.016313769572418587\ \(0\)\
\-\ cells\\:\\ 0\\.014529102590035323\ \(0\)\
\-\ nephrectomy\\:\\ 0\\.013696753386330394\ \(0\)\
\-\ it\\:\\ 0\\.013574900244049587\ \(0\)\
\-\ vein\\:\\ 0\\.013110671330095195\ \(0\)\
\-\ doxorubicin\\:\\ 0\\.013094970518059164\ \(0\)\
\-\ kidney\\:\\ 0\\.012764876841201454\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.012634761256196602\ \(0\)\
\-\ italy\\:\\ 0\\.012460096712320139\ \(0\)\
\-\ nwtsg\\:\\ 0\\.012460096712320139\ \(0\)\
\-\ percentile\\:\\ 0\\.012338769223489412\ \(0\)\
\-\ considerable\\:\\ 0\\.012338769223489412\ \(0\)\
\-\ is\\:\\ 0\\.012318737901008124\ \(0\)\
\-\ d\\:\\ 0\\.012047043201034509\ \(0\)\
\-\ iii\\:\\ 0\\.011339921920093969\ \(0\)\
\-\ \\,\\:\\ 0\\.011287557502134244\ \(0\)\
\-\ mass\\:\\ 0\\.010918723032027094\ \(0\)\
\-\ immunostains\\:\\ 0\\.010907287823743304\ \(0\)\
\-\ metanephric\\:\\ 0\\.010500670053493437\ \(0\)\
\-\ ii\\:\\ 0\\.010418712958426642\ \(0\)\
\-\ pseudocapsule\\:\\ 0\\.010185272807819643\ \(0\)\
\-\ i\\:\\ 0\\.009985341894638896\ \(0\)\
\-\ unfavorable\\:\\ 0\\.009927574494329953\ \(0\)\
\-\ or\\:\\ 0\\.009909059000347636\ \(0\)\
\-\ cm\\:\\ 0\\.009718541842333507\ \(0\)\
\-\ ivc\\:\\ 0\\.00965266123023007\ \(0\)\
\-\ nephroblastomatosis\\:\\ 0\\.009520956724080088\ \(0\)\
\-\ nephrogenic\\:\\ 0\\.009520956724080088\ \(0\)\
\-\ may\\:\\ 0\\.009272295817870577\ \(0\)\
\-\ infiltrated\\:\\ 0\\.009205559478406292\ \(0\)\
\-\ age\\:\\ 0\\.009190495849979882\ \(0\)\
\-\ course\\:\\ 0\\.009115283232383437\ \(0\)\
\-\ abdominal\\:\\ 0\\.009056901363061972\ \(0\)\
\-\ rests\\:\\ 0\\.008947861164916604\ \(0\)\
\-\ histologically\\:\\ 0\\.008541243394666737\ \(0\)\
\-\ thought\\:\\ 0\\.008337914843915464\ \(0\)\
\-\ are\\:\\ 0\\.008232324187488352\ \(0\)\
\-\ week\\:\\ 0\\.008203577154284743\ \(0\)\
\-\ cell\\:\\ 0\\.008156327602761436\ \(0\)\
\-\ craniocaudal\\:\\ 0\\.008091132113933827\ \(0\)\
\-\ sarcoma\\:\\ 0\\.008066890027993446\ \(0\)\
\-\ blue\\:\\ 0\\.007968147835503253\ \(0\)\
\-\ excretion\\:\\ 0\\.007801670046589638\ \(0\)\
\-\ and\\/or\\:\\ 0\\.007656915343229051\ \(0\)\
\-\ excised\\:\\ 0\\.007606404550503677\ \(0\)\
\-\ stromal\\:\\ 0\\.007518036554770343\ \(0\)\
\-\ preoperative\\:\\ 0\\.007395052276339771\ \(0\)\
\-\ visualized\\:\\ 0\\.007333425051507743\ \(0\)\
\-\ her\\:\\ 0\\.007263354511618192\ \(0\)\
\-\ complications\\:\\ 0\\.0071791649364213225\ \(0\)\
\-\ abdomen\\:\\ 0\\.007155856573556739\ \(0\)\
\-\ associated\\:\\ 0\\.007125309406034282\ \(0\)\
\-\ 24\\:\\ 0\\.0070440784041539565\ \(0\)\
\-\ postoperative\\:\\ 0\\.007018191974920763\ \(0\)\
\-\ right\\:\\ 0\\.00700915109555801\ \(0\)\
\-\ cystic\\:\\ 0\\.0069671595964714015\ \(0\)\
\-\ staging\\:\\ 0\\.006959290637252115\ \(0\)\
\-\ focal\\:\\ 0\\.006898921849154493\ \(0\)\
\-\ peak\\:\\ 0\\.006875299936940029\ \(0\)\
\-\ childhood\\:\\ 0\\.006796021538846681\ \(0\)\
\-\ clear\\:\\ 0\\.006698642996070626\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.00666189785892934\ \(0\)\
\-\ involvement\\:\\ 0\\.006640152628892897\ \(0\)\
\-\ iv\\:\\ 0\\.006611501634193131\ \(0\)\
\-\ been\\:\\ 0\\.0065718583447745334\ \(0\)\
\-\ at\\:\\ 0\\.006545657401168243\ \(0\)\
\-\ but\\:\\ 0\\.006439940993051369\ \(0\)\
\-\ differentiation\\:\\ 0\\.006435107486820046\ \(0\)\
\-\ biopsy\\:\\ 0\\.006427618180148608\ \(0\)\
\-\ the\\:\\ 0\\.0063506738556435875\ \(0\)\
\-\ surgical\\:\\ 0\\.006347073393114677\ \(0\)\
\-\ isolated\\:\\ 0\\.006284198687631769\ \(0\)\
\-\ each\\:\\ 0\\.006248861158012804\ \(0\)\
\-\ 137\\/90\\:\\ 0\\.0062300483561600695\ \(0\)\
\-\ 11kg\\:\\ 0\\.0062300483561600695\ \(0\)\
\-\ 80\\.6cm\\:\\ 0\\.0062300483561600695\ \(0\)\
\-\ 16\\.9\\:\\ 0\\.0062300483561600695\ \(0\)\
\-\ 730\\:\\ 0\\.0062300483561600695\ \(0\)\
\-\ proportionate\\:\\ 0\\.0062300483561600695\ \(0\)\
\-\ labial\\:\\ 0\\.0062300483561600695\ \(0\)\
\-\ chromogranin\\:\\ 0\\.0062300483561600695\ \(0\)\
\-\ 0\\.2mg\\/kg\\:\\ 0\\.0062300483561600695\ \(0\)\
\-\ 100\\-110\\/70\\:\\ 0\\.0062300483561600695\ \(0\)\
\-\ tumor\\-induced\\:\\ 0\\.0062300483561600695\ \(0\)\
\-\ 2\\.5\\-year\\-old\\:\\ 0\\.0062300483561600695\ \(0\)\
\-\ air\\-evac\\:\\ 0\\.0062300483561600695\ \(0\)\
\-\ non\\-hematogenous\\:\\ 0\\.0062300483561600695\ \(0\)\
\-\ 1080\\:\\ 0\\.0062300483561600695\ \(0\)\
\-\ 5th\\:\\ 0\\.006214385605893852\ \(0\)\
\-\ neoplasm\\:\\ 0\\.006169943270484653\ \(0\)\
\-\ collecting\\:\\ 0\\.006164199473799279\ \(0\)\
\-\ although\\:\\ 0\\.006118577980021067\ \(0\)\
\-\ obvious\\:\\ 0\\.0060999417012526265\ \(0\)\
\-\ thrombus\\:\\ 0\\.0060999417012526265\ \(0\)\
\-\ areas\\:\\ 0\\.00609614241253583\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.006038478645507412\ \(0\)\
\-\ in\\:\\ 0\\.005956144595621978\ \(0\)\
\-\ components\\:\\ 0\\.0059230326652752316\ \(0\)\
\-\ higher\\:\\ 0\\.0059230326652752316\ \(0\)\
\-\ positive\\:\\ 0\\.00587890937869424\ \(0\)\
\-\ invasion\\:\\ 0\\.005816308209433331\ \(0\)\
\-\ completely\\:\\ 0\\.005803516922479384\ \(0\)\
\-\ lead\\:\\ 0\\.0057908403571327255\ \(0\)\
\-\ into\\:\\ 0\\.005747919061370196\ \(0\)\
\-\ vimentin\\:\\ 0\\.005740191691453394\ \(0\)\
\-\ lca\\:\\ 0\\.005740191691453394\ \(0\)\
\-\ synaptophysin\\:\\ 0\\.005740191691453394\ \(0\)\
\-\ margination\\:\\ 0\\.005740191691453394\ \(0\)\
\-\ glomeruli\\:\\ 0\\.005740191691453394\ \(0\)\
\-\ distorts\\:\\ 0\\.005740191691453394\ \(0\)\
\-\ chances\\:\\ 0\\.005740191691453394\ \(0\)\
\-\ while\\:\\ 0\\.005700316409580876\ \(0\)\
\-\ normal\\:\\ 0\\.00568033549653329\ \(0\)\
\-\ has\\:\\ 0\\.0056703179169409115\ \(0\)\
\-\ most\\:\\ 0\\.005576919128559932\ \(0\)\
\-\ local\\:\\ 0\\.005547942467483738\ \(0\)\
\-\ incidence\\:\\ 0\\.0055373549456050695\ \(0\)\
\-\ node\\:\\ 0\\.005526846142089143\ \(0\)\
\-\ no\\:\\ 0\\.005472789651119588\ \(0\)\
\-\ 36\\.2\\:\\ 0\\.005453643911871652\ \(0\)\
\-\ shrinkage\\:\\ 0\\.005453643911871652\ \(0\)\
\-\ blastema\\:\\ 0\\.005453643911871652\ \(0\)\
\-\ inoperable\\:\\ 0\\.005453643911871652\ \(0\)\
\-\ to\\:\\ 0\\.005432668517295939\ \(0\)\
\-\ a\\:\\ 0\\.0053253683636419955\ \(0\)\
\-\ child\\:\\ 0\\.005286706160752892\ \(0\)\
\-\ consolable\\:\\ 0\\.005250335026746719\ \(0\)\
\-\ weakly\\:\\ 0\\.005250335026746719\ \(0\)\
\-\ 12\\.3\\:\\ 0\\.005250335026746719\ \(0\)\
\-\ assigned\\:\\ 0\\.005250335026746719\ \(0\)\
\-\ bp\\:\\ 0\\.005243212650269848\ \(0\)\
\-\ round\\:\\ 0\\.005217744797969243\ \(0\)\
\-\ that\\:\\ 0\\.005215479606214923\ \(0\)\
\-\ parenchyma\\:\\ 0\\.005143984016102712\ \(0\)\
\-\ 112\\:\\ 0\\.005092636403909822\ \(0\)\
\-\ keratin\\:\\ 0\\.005092636403909822\ \(0\)\
\-\ captopril\\:\\ 0\\.005092636403909822\ \(0\)\
\-\ 15\\.4\\:\\ 0\\.005092636403909822\ \(0\)\
\-\ bathing\\:\\ 0\\.005092636403909822\ \(0\)\
\-\ consistently\\:\\ 0\\.005092636403909822\ \(0\)\
\-\ comprised\\:\\ 0\\.005092636403909822\ \(0\)\
\-\ intralobular\\:\\ 0\\.005092636403909822\ \(0\)\
\-\ radiologically\\:\\ 0\\.005092636403909822\ \(0\)\
\-\ cgy\\:\\ 0\\.005092636403909822\ \(0\)\
\-\ 40\\:\\ 0\\.005081501906555722\ \(0\)\
\-\ 8cm\\:\\ 0\\.004963787247164977\ \(0\)\
\-\ recommends\\:\\ 0\\.004963787247164977\ \(0\)\
\-\ spill\\:\\ 0\\.004963787247164977\ \(0\)\
\-\ appear\\:\\ 0\\.004943319335861882\ \(0\)\
\-\ results\\:\\ 0\\.004875678316529536\ \(0\)\
\-\ lymph\\:\\ 0\\.004875678316529536\ \(0\)\
\-\ c\\/c\\/e\\:\\ 0\\.004854846837393063\ \(0\)\
\-\ precursor\\:\\ 0\\.004854846837393063\ \(0\)\
\-\ sagittal\\:\\ 0\\.004817451098948946\ \(0\)\
\-\ solid\\:\\ 0\\.004817451098948946\ \(0\)\
\-\ necrosis\\:\\ 0\\.004767633517236331\ \(0\)\
\-\ crying\\:\\ 0\\.004760478362040044\ \(0\)\
\-\ distributions\\:\\ 0\\.004760478362040044\ \(0\)\
\-\ etoposide\\:\\ 0\\.004760478362040044\ \(0\)\
\-\ rate\\:\\ 0\\.004707733555442887\ \(0\)\
\-\ 10\\.5\\:\\ 0\\.004677239467583236\ \(0\)\
\-\ sedated\\:\\ 0\\.004677239467583236\ \(0\)\
\-\ tubules\\:\\ 0\\.004677239467583236\ \(0\)\
\-\ be\\:\\ 0\\.004656384181427311\ \(0\)\
\-\ about\\:\\ 0\\.0046559116694053024\ \(0\)\
\-\ structures\\:\\ 0\\.004650269236515498\ \(0\)\
\-\ based\\:\\ 0\\.004605922773522206\ \(0\)\
\-\ 7\\.7\\:\\ 0\\.004602779739203146\ \(0\)\
\-\ intrarenal\\:\\ 0\\.004602779739203146\ \(0\)\
\-\ easy\\:\\ 0\\.004602779739203146\ \(0\)\
\-\ \\(\\:\\ 0\\.004594526880703\ \(0\)\
\-\ \\)\\:\\ 0\\.004538402281992753\ \(0\)\
\-\ tumors\\:\\ 0\\.004536701565612015\ \(0\)\
\-\ perineal\\:\\ 0\\.004535422721673588\ \(0\)\
\-\ suboptimal\\:\\ 0\\.004535422721673588\ \(0\)\
\-\ claw\\:\\ 0\\.004535422721673588\ \(0\)\
\-\ 5\\.2\\:\\ 0\\.004535422721673588\ \(0\)\
\-\ wramc\\:\\ 0\\.004535422721673588\ \(0\)\
\-\ neonates\\:\\ 0\\.004535422721673588\ \(0\)\
\-\ cure\\:\\ 0\\.004535422721673588\ \(0\)\
\-\ which\\:\\ 0\\.004509242649448901\ \(0\)\
\-\ tortuosity\\:\\ 0\\.004473930582458302\ \(0\)\
\-\ grows\\:\\ 0\\.004473930582458302\ \(0\)\
\-\ \\+bs\\:\\ 0\\.004417363297883364\ \(0\)\
\-\ umbilicus\\:\\ 0\\.004417363297883364\ \(0\)\
\-\ bid\\:\\ 0\\.004417363297883364\ \(0\)\
\-\ 2004\\.\\:\\ 0\\.004417363297883364\ \(0\)\
\-\ ap\\:\\ 0\\.0044171858228161665\ \(0\)\
\-\ pelvis\\:\\ 0\\.004388821776101242\ \(0\)\
\-\ presence\\:\\ 0\\.0043841492840383444\ \(0\)\
\-\ 2\\-12\\:\\ 0\\.004364990172686388\ \(0\)\
\-\ seem\\:\\ 0\\.004364990172686388\ \(0\)\
\-\ breakdown\\:\\ 0\\.004364990172686388\ \(0\)\
\-\ cyclophosphamide\\:\\ 0\\.004364990172686388\ \(0\)\
\-\ keep\\:\\ 0\\.004316231959621404\ \(0\)\
\-\ extension\\:\\ 0\\.004311416708383962\ \(0\)\
\-\ would\\:\\ 0\\.004298186400596593\ \(0\)\
\-\ \\;\\:\\ 0\\.004294179198132707\ \(0\)\
\-\ effect\\:\\ 0\\.004276407424832855\ \(0\)\
\-\ i\\.e\\.\\:\\ 0\\.004270621697333369\ \(0\)\
\-\ u\\/s\\:\\ 0\\.004270621697333369\ \(0\)\
\-\ notably\\:\\ 0\\.004270621697333369\ \(0\)\
\-\ lacks\\:\\ 0\\.004270621697333369\ \(0\)\
\-\ national\\:\\ 0\\.004270621697333369\ \(0\)\
\-\ pediatrician\\:\\ 0\\.004227777441632708\ \(0\)\
\-\ guidelines\\:\\ 0\\.004227777441632708\ \(0\)\
\-\ and\\:\\ 0\\.004198089886334424\ \(0\)\
\-\ c\\/w\\:\\ 0\\.004187382802876561\ \(0\)\
\-\ genitalia\\:\\ 0\\.004187382802876561\ \(0\)\
\-\ side\\:\\ 0\\.0041843766809386155\ \(0\)\
\-\ small\\:\\ 0\\.004173657846744421\ \(0\)\
\-\ diagnosis\\:\\ 0\\.004160182326742939\ \(0\)\
\-\ rashes\\:\\ 0\\.004149172752508875\ \(0\)\
\-\ architecture\\:\\ 0\\.004149172752508875\ \(0\)\
\-\ capsular\\:\\ 0\\.004149172752508875\ \(0\)\
\-\ for\\:\\ 0\\.004122166211407576\ \(0\)\
\-\ ht\\:\\ 0\\.004112923074496472\ \(0\)\
\-\ resp\\:\\ 0\\.004078442393104647\ \(0\)\
\-\ immature\\:\\ 0\\.004078442393104647\ \(0\)\
\-\ implants\\:\\ 0\\.004078442393104647\ \(0\)\
\-\ bmi\\:\\ 0\\.004045566056966913\ \(0\)\
\-\ adulthood\\:\\ 0\\.004045566056966913\ \(0\)\
\-\ cases\\:\\ 0\\.004023760938489233\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.004020150649012065\ \(0\)\
\-\ measurements\\:\\ 0\\.004014151383771977\ \(0\)\
\-\ pathologically\\:\\ 0\\.004014151383771977\ \(0\)\
\-\ inspection\\:\\ 0\\.003984073917751627\ \(0\)\
\-\ tends\\:\\ 0\\.003984073917751627\ \(0\)\
\-\ penetration\\:\\ 0\\.003984073917751627\ \(0\)\
\-\ gu\\:\\ 0\\.003955224451659574\ \(0\)\
\-\ functioning\\:\\ 0\\.00392750663317669\ \(0\)\
\-\ have\\:\\ 0\\.003923190272152138\ \(0\)\
\-\ lateral\\:\\ 0\\.003915197269875372\ \(0\)\
\-\ biopsies\\:\\ 0\\.003900835023294819\ \(0\)\
\-\ march\\:\\ 0\\.003900835023294819\ \(0\)\
\-\ hematogenous\\:\\ 0\\.003900835023294819\ \(0\)\
\-\ pcp\\:\\ 0\\.0038263752949147293\ \(0\)\
\-\ found\\:\\ 0\\.003806396628200865\ \(0\)\
\-\ unlike\\:\\ 0\\.0038032022752518386\ \(0\)\
\-\ oropharynx\\:\\ 0\\.003780765032626693\ \(0\)\
\-\ prophylaxis\\:\\ 0\\.003780765032626693\ \(0\)\
\-\ after\\:\\ 0\\.003748412443694422\ \(0\)\
\-\ supple\\:\\ 0\\.0037379207769260327\ \(0\)\
\-\ ctab\\:\\ 0\\.0037379207769260327\ \(0\)\
\-\ ext\\:\\ 0\\.0036975261381698857\ \(0\)\
\-\ ewing\\:\\ 0\\.0036975261381698857\ \(0\)\
\-\ rash\\:\\ 0\\.0036781629055281082\ \(0\)\
\-\ compressed\\:\\ 0\\.0036781629055281082\ \(0\)\
\-\ epithelial\\:\\ 0\\.0036781629055281082\ \(0\)\
\-\ morbidity\\:\\ 0\\.0036781629055281082\ \(0\)\
\-\ radiotherapy\\:\\ 0\\.0036781629055281082\ \(0\)\
\-\ diffuse\\:\\ 0\\.003656547590636487\ \(0\)\
\-\ target\\:\\ 0\\.0036409588535949483\ \(0\)\
\-\ proliferation\\:\\ 0\\.0036409588535949483\ \(0\)\
\-\ confined\\:\\ 0\\.0036409588535949483\ \(0\)\
\-\ documented\\:\\ 0\\.003623066409789796\ \(0\)\
\-\ specimen\\:\\ 0\\.003623066409789796\ \(0\)\
\-\ of\\:\\ 0\\.0036227330283473435\ \(0\)\
\-\ negative\\:\\ 0\\.0036072369772083028\ \(0\)\
\-\ there\\:\\ 0\\.0035949556366501444\ \(0\)\
\-\ infiltrate\\:\\ 0\\.0035885857283979713\ \(0\)\
\-\ ultrasound\\:\\ 0\\.0035832121342845276\ \(0\)\
\-\ seen\\:\\ 0\\.0035801292192247846\ \(0\)\
\-\ from\\:\\ 0\\.003580030284534876\ \(0\)\
\-\ prominence\\:\\ 0\\.003571956401606315\ \(0\)\
\-\ confused\\:\\ 0\\.003571956401606315\ \(0\)\
\-\ differentiate\\:\\ 0\\.003555709392260238\ \(0\)\
\-\ whole\\:\\ 0\\.003555709392260238\ \(0\)\
\-\ 3\\-4\\:\\ 0\\.0035398275153329883\ \(0\)\
\-\ varying\\:\\ 0\\.0035398275153329883\ \(0\)\
\-\ 3\\.5\\:\\ 0\\.0035242947190653024\ \(0\)\
\-\ parents\\:\\ 0\\.0035090959874603815\ \(0\)\
\-\ beyond\\:\\ 0\\.0035090959874603815\ \(0\)\
\-\ evaluation\\:\\ 0\\.003508464729083827\ \(0\)\
\-\ reconstruction\\:\\ 0\\.003494217253044952\ \(0\)\
\-\ extended\\:\\ 0\\.003494217253044952\ \(0\)\
\-\ level\\:\\ 0\\.003481115233423225\ \(0\)\
\-\ ducts\\:\\ 0\\.0034653677869528987\ \(0\)\
\-\ surrounded\\:\\ 0\\.003451372997344291\ \(0\)\
\-\ intraluminal\\:\\ 0\\.0034241883465825984\ \(0\)\
\-\ she\\:\\ 0\\.003390510447285049\ \(0\)\
\-\ edge\\:\\ 0\\.0033852768432730378\ \(0\)\
\-\ plane\\:\\ 0\\.003372768308220458\ \(0\)\
\-\ however\\:\\ 0\\.0033630643895364953\ \(0\)\
\-\ according\\:\\ 0\\.0033604773239717875\ \(0\)\
\-\ temp\\:\\ 0\\.003348396452339773\ \(0\)\
\-\ cv\\:\\ 0\\.003348396452339773\ \(0\)\
\-\ making\\:\\ 0\\.003348396452339773\ \(0\)\
\-\ notable\\:\\ 0\\.0033365186302080547\ \(0\)\
\-\ contain\\:\\ 0\\.0033365186302080547\ \(0\)\
\-\ gen\\:\\ 0\\.0033248371447301673\ \(0\)\
\-\ abnormally\\:\\ 0\\.0033248371447301673\ \(0\)\
\-\ shows\\:\\ 0\\.003320669540252832\ \(0\)\
\-\ fifth\\:\\ 0\\.0033133456105451636\ \(0\)\
\-\ true\\:\\ 0\\.0033133456105451636\ \(0\)\
\-\ consists\\:\\ 0\\.0033133456105451636\ \(0\)\
\-\ elements\\:\\ 0\\.0033133456105451636\ \(0\)\
\-\ v\\:\\ 0\\.0033133456105451636\ \(0\)\
\-\ hamartoma\\:\\ 0\\.00330203794881623\ \(0\)\
\-\ capsule\\:\\ 0\\.003269161612678496\ \(0\)\
\-\ alone\\:\\ 0\\.003269161612678496\ \(0\)\
\-\ ureter\\:\\ 0\\.00325853413750921\ \(0\)\
\-\ murmurs\\:\\ 0\\.0032480641122193577\ \(0\)\
\-\ cn\\:\\ 0\\.0032480641122193577\ \(0\)\
\-\ superficial\\:\\ 0\\.0032275782204361403\ \(0\)\
\-\ improve\\:\\ 0\\.003217553743410023\ \(0\)\
\-\ variable\\:\\ 0\\.003217553743410023\ \(0\)\
\-\ exclude\\:\\ 0\\.0032076694734632103\ \(0\)\
\-\ every\\:\\ 0\\.0032076694734632103\ \(0\)\
\-\ abd\\:\\ 0\\.0031979215426276375\ \(0\)\
\-\ well\\-circumscribed\\:\\ 0\\.0031979215426276375\ \(0\)\
\-\ occurred\\:\\ 0\\.0031979215426276375\ \(0\)\
\-\ height\\:\\ 0\\.0031788200073711577\ \(0\)\
\-\ grossly\\:\\ 0\\.0031694594230955242\ \(0\)\
\-\ evidence\\:\\ 0\\.003166703298045057\ \(0\)\
\-\ dose\\:\\ 0\\.0031602212029065825\ \(0\)\
\-\ group\\:\\ 0\\.0031420993438158844\ \(0\)\
\-\ peritoneal\\:\\ 0\\.0031420993438158844\ \(0\)\
\-\ anatomy\\:\\ 0\\.003124430579006402\ \(0\)\
\-\ pulse\\:\\ 0\\.0031157591354786184\ \(0\)\
\-\ neuro\\:\\ 0\\.0031157591354786184\ \(0\)\
\-\ clearly\\:\\ 0\\.003107192802946926\ \(0\)\
\-\ nontender\\:\\ 0\\.003098729063691296\ \(0\)\
\-\ neoplastic\\:\\ 0\\.00309036548938246\ \(0\)\
\-\ rrr\\:\\ 0\\.0030820997368996394\ \(0\)\
\-\ types\\:\\ 0\\.0030820997368996394\ \(0\)\
\-\ corresponding\\:\\ 0\\.0030739295443900456\ \(0\)\
\-\ adrenal\\:\\ 0\\.0030578671761373557\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.0030421617791163594\ \(0\)\
\-\ more\\:\\ 0\\.0030207439000878673\ \(0\)\
\-\ iliac\\:\\ 0\\.003011760800258627\ \(0\)\
\-\ characterized\\:\\ 0\\.003004360588338277\ \(0\)\
\-\ overall\\:\\ 0\\.003004360588338277\ \(0\)\
\-\ immediately\\:\\ 0\\.0029970370639315303\ \(0\)\
\-\ solitary\\:\\ 0\\.0029970370639315303\ \(0\)\
\-\ unilateral\\:\\ 0\\.0029970370639315303\ \(0\)\
\-\ residual\\:\\ 0\\.0029970370639315303\ \(0\)\
\-\ resected\\:\\ 0\\.0029897886539193824\ \(0\)\
\-\ definitive\\:\\ 0\\.002982613833096755\ \(0\)\
\-\ firm\\:\\ 0\\.0029615163326376158\ \(0\)\
\-\ bilateral\\:\\ 0\\.0029311911368402033\ \(0\)\
\-\ part\\:\\ 0\\.002927695822971443\ \(0\)\
\-\ heent\\:\\ 0\\.002921121693881469\ \(0\)\
\-\ distended\\:\\ 0\\.002921121693881469\ \(0\)\
\-\ lumen\\:\\ 0\\.0029081541047166655\ \(0\)\
\-\ rarely\\:\\ 0\\.0028954201785663628\ \(0\)\
\-\ vital\\:\\ 0\\.002889138236928733\ \(0\)\
\-\ followup\\:\\ 0\\.0028829116435137828\ \(0\)\
\-\ c\\:\\ 0\\.002870620659265112\ \(0\)\
\-\ prognosis\\:\\ 0\\.0028645544093065314\ \(0\)\
\-\ hematuria\\:\\ 0\\.0028645544093065314\ \(0\)\
\-\ tissue\\:\\ 0\\.0028627861320884716\ \(0\)\
\-\ reflexes\\:\\ 0\\.0028585397876330974\ \(0\)\
\-\ markedly\\:\\ 0\\.0028585397876330974\ \(0\)\
\-\ 28\\:\\ 0\\.0028466619655013797\ \(0\)\
\-\ involve\\:\\ 0\\.0028466619655013797\ \(0\)\
\-\ without\\:\\ 0\\.0028438348641104737\ \(0\)\
\-\ teratoma\\:\\ 0\\.0028234889458384886\ \(0\)\
\-\ form\\:\\ 0\\.0028234889458384886\ \(0\)\
\-\ \\%\\:\\ 0\\.0028174148881215653\ \(0\)\
\-\ gait\\:\\ 0\\.002812181284109555\ \(0\)\
\-\ unable\\:\\ 0\\.002790094680926442\ \(0\)\
\-\ regions\\:\\ 0\\.0027634230710445714\ \(0\)\
\-\ symmetric\\:\\ 0\\.0027582074475126827\ \(0\)\
\-\ margins\\:\\ 0\\.0027427876260323718\ \(0\)\
\-\ visual\\:\\ 0\\.0027377215557294657\ \(0\)\
\-\ well\\:\\ 0\\.002732269898188906\ \(0\)\
\-\ present\\:\\ 0\\.0027279275673946016\ \(0\)\
\-\ cavity\\:\\ 0\\.002643353080376446\ \(0\)\
\-\ large\\:\\ 0\\.0026410493736128333\ \(0\)\
\-\ point\\:\\ 0\\.0026389498650049715\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0026383338539267645\ \(0\)\
\-\ recurrence\\:\\ 0\\.0026345739142997274\ \(0\)\
\-\ life\\:\\ 0\\.0026345739142997274\ \(0\)\
\-\ either\\:\\ 0\\.0026302248926923927\ \(0\)\
\-\ development\\:\\ 0\\.0026302248926923927\ \(0\)\
\-\ growth\\:\\ 0\\.002625902470771943\ \(0\)\
\-\ below\\:\\ 0\\.002621606325134924\ \(0\)\
\-\ 18\\:\\ 0\\.002621606325134924\ \(0\)\
\-\ not\\:\\ 0\\.0026179901167673538\ \(0\)\
\-\ had\\:\\ 0\\.002606148154403828\ \(0\)\
\-\ foci\\:\\ 0\\.002592243072192965\ \(0\)\
\-\ displacement\\:\\ 0\\.0025881461692358436\ \(0\)\
\-\ measures\\:\\ 0\\.00258407287968337\ \(0\)\
\-\ gland\\:\\ 0\\.002571992008051356\ \(0\)\
\-\ findings\\:\\ 0\\.002570794255533512\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.0025680105114306807\ \(0\)\
\-\ rupture\\:\\ 0\\.002564051320230207\ \(0\)\
\-\ with\\:\\ 0\\.0025633423737007645\ \(0\)\
\-\ defined\\:\\ 0\\.002544581389651952\ \(0\)\
\-\ ct\\:\\ 0\\.0025342126927039776\ \(0\)\
\-\ increase\\:\\ 0\\.002533151807146227\ \(0\)\
\-\ s\\/p\\:\\ 0\\.002533151807146227\ \(0\)\
\-\ outside\\:\\ 0\\.002533151807146227\ \(0\)\
\-\ just\\:\\ 0\\.0025219041355519518\ \(0\)\
\-\ coronal\\:\\ 0\\.0025145039236316017\ \(0\)\
\-\ an\\:\\ 0\\.0025052965320524305\ \(0\)\
\-\ arising\\:\\ 0\\.0024999319892127073\ \(0\)\
\-\ views\\:\\ 0\\.002489196889923679\ \(0\)\
\-\ occurs\\:\\ 0\\.0024786224216009137\ \(0\)\
\-\ prominent\\:\\ 0\\.0024786224216009137\ \(0\)\
\-\ excision\\:\\ 0\\.0024786224216009137\ \(0\)\
\-\ initially\\:\\ 0\\.0024579366390566643\ \(0\)\
\-\ bladder\\:\\ 0\\.002451173776147724\ \(0\)\
\-\ single\\:\\ 0\\.0024478164597105524\ \(0\)\
\-\ evaluate\\:\\ 0\\.002441149299121606\ \(0\)\
\-\ considered\\:\\ 0\\.002437839158264768\ \(0\)\
\-\ includes\\:\\ 0\\.0024345444493560674\ \(0\)\
\-\ filling\\:\\ 0\\.0024312650291747934\ \(0\)\
\-\ range\\:\\ 0\\.0024312650291747934\ \(0\)\
\-\ complex\\:\\ 0\\.0024182974400099905\ \(0\)\
\-\ dysplasia\\:\\ 0\\.0023838167586181657\ \(0\)\
\-\ hypertension\\:\\ 0\\.0023807639945584366\ \(0\)\
\-\ system\\:\\ 0\\.0023777243607072773\ \(0\)\
\-\ \\#\\:\\ 0\\.002368683122926423\ \(0\)\
\-\ cysts\\:\\ 0\\.0023656948995274675\ \(0\)\
\-\ \\<\\:\\ 0\\.002330788358658509\ \(0\)\
\-\ skin\\:\\ 0\\.0023195257492854967\ \(0\)\
\-\ 7\\:\\ 0\\.0023139610450940437\ \(0\)\
\-\ lungs\\:\\ 0\\.0022867763943323505\ \(0\)\
\-\ its\\:\\ 0\\.0022788208080958593\ \(0\)\
\-\ view\\:\\ 0\\.0022657573348279425\ \(0\)\
\-\ throughout\\:\\ 0\\.002260598817173093\ \(0\)\
\-\ metastasis\\:\\ 0\\.002260598817173093\ \(0\)\
\-\ 8\\:\\ 0\\.0022580336100702105\ \(0\)\
\-\ appears\\:\\ 0\\.0022478648910227903\ \(0\)\
\-\ could\\:\\ 0\\.0022279561440498603\ \(0\)\
\-\ intact\\:\\ 0\\.002218208213214287\ \(0\)\
\-\ congenital\\:\\ 0\\.0022085929114080832\ \(0\)\
\-\ sinus\\:\\ 0\\.0022085929114080832\ \(0\)\
\-\ they\\:\\ 0\\.002175933658294916\ \(0\)\
\-\ weight\\:\\ 0\\.0021646259965659824\ \(0\)\
\-\ then\\:\\ 0\\.0021490932002982965\ \(0\)\
\-\ palpable\\:\\ 0\\.0021403682279857177\ \(0\)\
\-\ obstruction\\:\\ 0\\.0021296113417593183\ \(0\)\
\-\ girl\\:\\ 0\\.0021232349335616944\ \(0\)\
\-\ \\&\\:\\ 0\\.0021211221852589623\ \(0\)\
\-\ was\\:\\ 0\\.00209528803296188\ \(0\)\
\-\ sign\\:\\ 0\\.0020921883404693077\ \(0\)\
\-\ liver\\:\\ 0\\.002082135343344681\ \(0\)\
\-\ given\\:\\ 0\\.002070257521212963\ \(0\)\
\-\ now\\:\\ 0\\.002064392642898691\ \(0\)\
\-\ does\\:\\ 0\\.0020605095903773896\ \(0\)\
\-\ on\\:\\ 0\\.002046335017287429\ \(0\)\
\-\ masses\\:\\ 0\\.0020414080551209098\ \(0\)\
\-\ this\\:\\ 0\\.0020377467420087626\ \(0\)\
\-\ three\\:\\ 0\\.002035776839821138\ \(0\)\
\-\ extending\\:\\ 0\\.0020301901405228246\ \(0\)\
\-\ first\\:\\ 0\\.00202649005991933\ \(0\)\
\-\ palpation\\:\\ 0\\.0020155046504226515\ \(0\)\
\-\ by\\:\\ 0\\.0020111249515828615\ \(0\)\
\-\ initial\\:\\ 0\\.0020011181224588747\ \(0\)\
\-\ flow\\:\\ 0\\.0019957977928328737\ \(0\)\
\-\ x\\:\\ 0\\.0019922730285141183\ \(0\)\
\-\ spine\\:\\ 0\\.0019887657568942387\ \(0\)\
\-\ study\\:\\ 0\\.001987018626756155\ \(0\)\
\-\ radiation\\:\\ 0\\.0019818030032242658\ \(0\)\
\-\ revealed\\:\\ 0\\.0019381440917781577\ \(0\)\
\-\ medial\\:\\ 0\\.0019316604336325454\ \(0\)\
\-\ further\\:\\ 0\\.0019204552238871082\ \(0\)\
\-\ follow\\:\\ 0\\.0019188688847677979\ \(0\)\
\-\ differential\\:\\ 0\\.0019172860984826357\ \(0\)\
\-\ image\\:\\ 0\\.0018863527677014846\ \(0\)\
\-\ resection\\:\\ 0\\.0018833326187422039\ \(0\)\
\-\ usually\\:\\ 0\\.0018338715575030098\ \(0\)\
\-\ some\\:\\ 0\\.0018338715575030098\ \(0\)\
\-\ only\\:\\ 0\\.001815838627904548\ \(0\)\
\-\ neck\\:\\ 0\\.0017733167046067014\ \(0\)\
\-\ years\\:\\ 0\\.0017733167046067014\ \(0\)\
\-\ 5\\:\\ 0\\.0017668978250488785\ \(0\)\
\-\ pulmonary\\:\\ 0\\.001764346508989444\ \(0\)\
\-\ \\.\\:\\ 0\\.0017561607963351513\ \(0\)\
\-\ lung\\:\\ 0\\.0017492290602393965\ \(0\)\
\-\ appearance\\:\\ 0\\.0017271424570562837\ \(0\)\
\-\ lymphoma\\:\\ 0\\.0017259354306639475\ \(0\)\
\-\ axial\\:\\ 0\\.0017235275449242907\ \(0\)\
\-\ abnormal\\:\\ 0\\.001722326671600644\ \(0\)\
\-\ through\\:\\ 0\\.0017151639706154548\ \(0\)\
\-\ weeks\\:\\ 0\\.001713977213357702\ \(0\)\
\-\ following\\:\\ 0\\.001713977213357702\ \(0\)\
\-\ edema\\:\\ 0\\.0017080731374072725\ \(0\)\
\-\ all\\:\\ 0\\.0017080731374072725\ \(0\)\
\-\ region\\:\\ 0\\.0017057252489323764\ \(0\)\
\-\ time\\:\\ 0\\.0017057252489323764\ \(0\)\
\-\ likely\\:\\ 0\\.0017033851349368596\ \(0\)\
\-\ months\\:\\ 0\\.0016494284768127684\ \(0\)\
\-\ presented\\:\\ 0\\.001646189141358593\ \(0\)\
\-\ if\\:\\ 0\\.0016386879390675867\ \(0\)\
\-\ up\\:\\ 0\\.0016239202480948574\ \(0\)\
\-\ lesions\\:\\ 0\\.0016166505345186909\ \(0\)\
\-\ therapy\\:\\ 0\\.0016145871351523767\ \(0\)\
\-\ due\\:\\ 0\\.0016115032883058937\ \(0\)\
\-\ common\\:\\ 0\\.0015804008565062876\ \(0\)\
\-\ these\\:\\ 0\\.0015716216904295688\ \(0\)\
\-\ anterior\\:\\ 0\\.0015553306175001677\ \(0\)\
\-\ both\\:\\ 0\\.0015421908061386015\ \(0\)\
\-\ soft\\:\\ 0\\.001470619621196855\ \(0\)\
\-\ noted\\:\\ 0\\.0014313930660442358\ \(0\)\
\-\ other\\:\\ 0\\.0013919707057967834\ \(0\)\
\-\ demonstrate\\:\\ 0\\.0013897188277972017\ \(0\)\
\-\ were\\:\\ 0\\.001371227093067082\ \(0\)\
\-\ lower\\:\\ 0\\.0013582064094444259\ \(0\)\
\-\ contrast\\:\\ 0\\.0013517849376734313\ \(0\)\
\-\ left\\:\\ 0\\.00135138553960836\ \(0\)\
\-\ \\'s\\:\\ 0\\.001331481709093318\ \(0\)\
\-\ case\\:\\ 0\\.001321204546195951\ \(0\)\
\-\ multiple\\:\\ 0\\.0012719477056390592\ \(0\)\
\-\ female\\:\\ 0\\.0012415266936027093\ \(0\)\
\-\ treatment\\:\\ 0\\.0012223441410606974\ \(0\)\
\-\ patient\\:\\ 0\\.0012107306444047886\ \(0\)\
\-\ also\\:\\ 0\\.0011905438824524038\ \(0\)\
\-\ within\\:\\ 0\\.0011520363310148986\ \(0\)\
\-\ as\\:\\ 0\\.0009134823363209383\ \(0\)\
\-\ year\\:\\ 0\\.00067569276980418\ \(0\)\
